158 related articles for article (PubMed ID: 17575109)
1. Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomes.
Herlevsen M; Oxford G; Owens CR; Conaway M; Theodorescu D
Mol Cancer Ther; 2007 Jun; 6(6):1804-13. PubMed ID: 17575109
[TBL] [Abstract][Full Text] [Related]
2. Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP).
Lehuédé C; Li X; Dauvillier S; Vaysse C; Franchet C; Clement E; Esteve D; Longué M; Chaltiel L; Le Gonidec S; Lazar I; Geneste A; Dumontet C; Valet P; Nieto L; Fallone F; Muller C
Breast Cancer Res; 2019 Jan; 21(1):7. PubMed ID: 30654824
[TBL] [Abstract][Full Text] [Related]
3. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
van Zon A; Mossink MH; Schoester M; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2004 Jul; 64(14):4887-92. PubMed ID: 15256459
[TBL] [Abstract][Full Text] [Related]
4. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line.
Huffman KE; Corey DR
Biochemistry; 2005 Feb; 44(7):2253-61. PubMed ID: 15709737
[TBL] [Abstract][Full Text] [Related]
5. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics.
Mossink MH; van Zon A; Fränzel-Luiten E; Schoester M; Kickhoefer VA; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2002 Dec; 62(24):7298-304. PubMed ID: 12499273
[TBL] [Abstract][Full Text] [Related]
7. Vaults: a ribonucleoprotein particle involved in drug resistance?
Mossink MH; van Zon A; Scheper RJ; Sonneveld P; Wiemer EA
Oncogene; 2003 Oct; 22(47):7458-67. PubMed ID: 14576851
[TBL] [Abstract][Full Text] [Related]
8. Vault mobility depends in part on microtubules and vaults can be recruited to the nuclear envelope.
van Zon A; Mossink MH; Houtsmuller AB; Schoester M; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
Exp Cell Res; 2006 Feb; 312(3):245-55. PubMed ID: 16310186
[TBL] [Abstract][Full Text] [Related]
9. Nuclear localization of the major vault protein in U373 cells.
Slesina M; Inman EM; Rome LH; Volknandt W
Cell Tissue Res; 2005 Jul; 321(1):97-104. PubMed ID: 15902504
[TBL] [Abstract][Full Text] [Related]
10. Direct activation of the human major vault protein gene by DNA-damaging agents.
Shimamoto Y; Sumizawa T; Haraguchi M; Gotanda T; Jueng HC; Furukawa T; Sakata R; Akiyama S
Oncol Rep; 2006 Mar; 15(3):645-52. PubMed ID: 16465425
[TBL] [Abstract][Full Text] [Related]
11. Major vault protein suppresses lung cancer cell proliferation by inhibiting STAT3 signaling pathway.
Bai H; Wang C; Qi Y; Xu J; Li N; Chen L; Jiang B; Zhu X; Zhang H; Li X; Yang Q; Ma J; Xu Y; Ben J; Chen Q
BMC Cancer; 2019 May; 19(1):454. PubMed ID: 31092229
[TBL] [Abstract][Full Text] [Related]
12. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.
Han M; Lv Q; Tang XJ; Hu YL; Xu DH; Li FZ; Liang WQ; Gao JQ
J Control Release; 2012 Oct; 163(2):136-44. PubMed ID: 22940126
[TBL] [Abstract][Full Text] [Related]
13. Major vault protein is expressed along the nucleus-neurite axis and associates with mRNAs in cortical neurons.
Paspalas CD; Perley CC; Venkitaramani DV; Goebel-Goody SM; Zhang Y; Kurup P; Mattis JH; Lombroso PJ
Cereb Cortex; 2009 Jul; 19(7):1666-77. PubMed ID: 19029061
[TBL] [Abstract][Full Text] [Related]
14. Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells.
Ikeda R; Iwashita K; Sumizawa T; Beppu S; Tabata S; Tajitsu Y; Shimamoto Y; Yoshida K; Furukawa T; Che XF; Yamaguchi T; Ushiyama M; Miyawaki A; Takeda Y; Yamamoto M; Zhao HY; Shibayama Y; Yamada K; Akiyama S
Exp Cell Res; 2008 Oct; 314(16):3017-26. PubMed ID: 18671966
[TBL] [Abstract][Full Text] [Related]
15. Expression of the Major Vault Protein (MVP) and Cellular Vault Particles in Fish.
Margiotta AL; Bain LJ; Rice CD
Anat Rec (Hoboken); 2017 Nov; 300(11):1981-1992. PubMed ID: 28710803
[TBL] [Abstract][Full Text] [Related]
16. The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals.
Steiner E; Holzmann K; Pirker C; Elbling L; Micksche M; Sutterlüty H; Berger W
J Cell Sci; 2006 Feb; 119(Pt 3):459-69. PubMed ID: 16418217
[TBL] [Abstract][Full Text] [Related]
17. 14-3-3ε boosts bleomycin-induced DNA damage response by inhibiting the drug-resistant activity of MVP.
Tang S; Bai C; Yang P; Chen X
J Proteome Res; 2013 Jun; 12(6):2511-24. PubMed ID: 23590642
[TBL] [Abstract][Full Text] [Related]
18. Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6.
Chen J; OuYang H; An X; Liu S
PLoS One; 2018; 13(1):e0191325. PubMed ID: 29346433
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and major vault protein in resistance to apoptosis in senescent cells by regulating ERK1/2 activation.
Pasillas MP; Shields S; Reilly R; Strnadel J; Behl C; Park R; Yates JR; Klemke R; Gonias SL; Coppinger JA
Mol Cell Proteomics; 2015 Jan; 14(1):1-14. PubMed ID: 24997994
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying lung resistance-related protein (LRP)-mediated doxorubicin resistance of non-small cell lung cancer cells.
Chen YL; Yang TY; Wu CL; Chen KC; Hsu SL; Hsueh CM
Chin J Physiol; 2016 Dec; 59(6):331-347. PubMed ID: 27817195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
